News

Gustave Roussy, the leading comprehensive cancer centre in Europe, is now recruiting for its 5th round for  the “Course of Excellence in Oncology - Fondation Philanthropia”. 

The Gustave Roussy 2015 Annual Report contains a review and the highlights of 2015, a year rich in events and innovations: launch of new unit, deployment of an extensive services program, transformation of the Chevilly-Larue site following the merger, significant scientific advances notably in immunotherapy and targeted therapies, investments in...

At this 52nd annual meeting of the world’s most important oncology conference, Gustave Roussy confirms its leading role in the development of three therapeutic strategies that are changing practice and transforming patient treatment:

• Immunotherapy is extending its application to new pathologies
• Precision medicine are becoming routine therapeutic...

Gustave Roussy is recalibrating services for patients and their families, to range from care to taking care. By launching the “Infiniment Vous, spirit of service at Gustave Roussy” programme, the Institute is placing the patient at the centre of its concerns, so offering continuing compassion as well as care. Gustave Roussy is committed to taking...

More cures and better cures. With the dual purpose of improving survival and reducing sequelae, Gustave Roussy is contributing to ambitious research programmes in Paediatric Oncology and to the management of young adults.

Gustave Roussy and all its personnel offer you their best wishes for 2016!

The Gustave Roussy 2014 annual report is presenting an outline of the achievements, highlights and key figures over the past year.

Compassion, commitment, creativity, dynamism and the sharing of expertise are the values that define Gustave Roussy and lead it to place innovation at the heart of its humanitarian, scientific, technological and...

Drawing on scientific and therapeutic innovations, technological and organisational advances, and a fresh approach to the patient-hospital relationship, the Gustave Roussy development project for 2015-2020 strives to achieve the levels of excellence and innovation demanded by the fight against cancer.

3 questions to Dr Charles Honoré, head of sarcoma surgery at Gustave Roussy

Co-organised by Gustave Roussy, the 13rd TAT Congress took place in Paris from the 2nd to the 4th of March. Presided over this year by Prof. Jean-Charles Soria, Head of the Drug Development Department (DITEP) at Gustave Roussy, the TAT congress is the first International Meeting on the early development of medicines in oncology.